Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Childhood Solid Tumor × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 125 Breast Neoplasms 91 Neoplasms 86 Colorectal Neoplasms 76 Recurrence 60 Prostatic Neoplasms 60 Neoplasm Metastasis 55 Leukemia, Myeloid, Acute 55 Ovarian Neoplasms 53 Multiple Myeloma 52 Pancreatic Neoplasms 50 Lung Neoplasms 46 Melanoma 44 Glioblastoma 42 Stomach Neoplasms 39 Lymphoma, Non-Hodgkin 38 Squamous Cell Carcinoma of Head and Neck 36 Lymphoma 36 Triple Negative Breast Neoplasms 35 Lymphoma, Large B-Cell, Diffuse 31 Leukemia, Lymphocytic, Chronic, B-Cell 30 Endometrial Neoplasms 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Carcinoma, Renal Cell 29 Carcinoma, Hepatocellular 29 Myelodysplastic Syndromes 28 Sarcoma 27 Lymphoma, Follicular 26 Small Cell Lung Carcinoma 25 Lymphoma, B-Cell 25

Interventions

Vinblastine 1 Nivolumab 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03585465 2026-03-18

Metro-PD1

Centre Oscar Lambret

Phase 1/2 Active not recruiting

Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡